Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug Combination”

2,877 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,877 results

Early research (Phase 1)WithdrawnNCT04500548
What this trial is testing

Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study

Who this might be right for
Constitutional Mismatch Repair Deficiency SyndromeHematopoietic and Lymphoid Cell NeoplasmLynch Syndrome+9 more
National Cancer Institute (NCI)
Very early researchUnknownNCT03465943
What this trial is testing

Different Preloads for Prevention of Hypotension in Patients Undergoing Elective CS Under Intrathecal Anesthesia

Who this might be right for
Hypotension Drug-Induced
Assiut University 60
Large-scale testing (Phase 3)Study completedNCT02804282
What this trial is testing

Product Design Clinical Performance Study of sc2Wear Furosemide Combination Product

Who this might be right for
Heart Failure
scPharmaceuticals, Inc. 74
Not applicableLooking for participantsNCT07115342
What this trial is testing

Effect of Combined Probiotics and Vitamin D on Symptoms of Allergic Rhinitis

Who this might be right for
Allergic RhinitisAllergic Rhinitis (AR)
Tanta University 120
Post-approval studies (Phase 4)Not Yet RecruitingNCT07485842
What this trial is testing

FuKe Qianjin Capsule Plus Antibiotics for Chronic Endometritis

Who this might be right for
Chronic Endometritis
Tianjin Medical University 300
Testing effectiveness (Phase 2)Study completedNCT05041062
What this trial is testing

Immunotherapy Drugs Nivolumab and Ipilimumab in Patients w/Resectable Malignant Peritoneal Mesothelioma

Who this might be right for
MesotheliomaPeritoneal Mesothelioma
University of Chicago 2
Early research (Phase 1)Active Not RecruitingNCT06537310
What this trial is testing

A Dose-escalation Study of RO7567132 as Single Agent and in Combination With Atezolizumab in Participants With Advanced Solid Tumors

Who this might be right for
Cancer-Neoplasms
Hoffmann-La Roche 34
Post-approval studies (Phase 4)WithdrawnNCT05661682
What this trial is testing

Tralement Versus a Fixed-dose Trace Element Combination Product to Evaluate Manganese Safety

Who this might be right for
Manganese Safety in Adults
American Regent, Inc.
Early research (Phase 1)Study completedNCT05025085
What this trial is testing

A Study Investigating AGEN1777 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Cancer
Agenus Inc. 25
Testing effectiveness (Phase 2)Looking for participantsNCT06953089
What this trial is testing

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

Who this might be right for
Solid Tumors
DualityBio Inc. 492
Early research (Phase 1)Ended earlyNCT04294160
What this trial is testing

Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer

Who this might be right for
BRAF V600 Colorectal Cancer
Novartis Pharmaceuticals 122
Early research (Phase 1)Study completedNCT03289962
What this trial is testing

Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors

Who this might be right for
MelanomaNon-Small Cell Lung CancerBladder Cancer+5 more
Genentech, Inc. 272
Testing effectiveness (Phase 2)Ended earlyNCT02490774
What this trial is testing

To Investigate the Pharmacological Effects, Drug Blood Levels and Safety of an Intrauterine System Releasing the Study Drug BAY1007626 in Comparison to Mirena and Jaydess in Healthy Young Women Treated for 90 Days to Determine the Drug Dose for Further Development

Who this might be right for
Contraception
Bayer 174
Testing effectiveness (Phase 2)Ended earlyNCT03519256
What this trial is testing

Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder

Who this might be right for
Urinary Bladder Neoplasms
Bristol-Myers Squibb 142
Post-approval studies (Phase 4)Study completedNCT00970528
What this trial is testing

Glucose Reduction by Early Acarbose Treatment in Basal Insulin

Who this might be right for
Diabetes Mellitus, Type 2
Bayer 124
Large-scale testing (Phase 3)Study completedNCT02342886
What this trial is testing

Shortening Treatment by Advancing Novel Drugs

Who this might be right for
Tuberculosis, Pulmonary, Drug SensitiveTuberculosis, Pulmonary, Multi Drug-resistant
Global Alliance for TB Drug Development 284
Early research (Phase 1)Ended earlyNCT03996473
What this trial is testing

Study to Test the Safety and How Radium-223 Dichloride an Alpha Particle-emitting Radioactive Agent Works in Combination With Pembrolizumab an Immune Checkpoint Inhibitor in Patients With Stage IV Non-small Cell Lung Cancer With Bone Metastases

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Bayer 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT04262466
What this trial is testing

Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors

Who this might be right for
Select Advanced Solid Tumors
Immunocore Ltd 410
Not applicableStudy completedNCT00000731
What this trial is testing

Evaluation of the Interaction Between Acetaminophen and Zidovudine

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 10
Large-scale testing (Phase 3)Study completedNCT04625972
What this trial is testing

Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults

Who this might be right for
COVID-19
AstraZeneca 1,131
Load More Results